Abstract

Rapid diagnostic clinics (RDCs) were set up by NHS England to provide an alternative pathway for patients with non-specific symptoms (e.g. weight loss and fatigue) concerning of malignancy, who are not suitable for a site-specific route. The aim of the current study was to perform a preliminary analysis of the serum biomarker levels of patients attending an RDC and subsequently diagnosed with cancer, as compared to those patients diagnosed with a mild benign disease or with no clear organic cause for their symptoms.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call